Most Recent
The contingency fee rate sought by Shine Lawyers in its bid to vary a group costs order in a class action against EML Payments has been revealed as the percentage profit it initially proposed to a judge, who took an ax to it three years ago.
Piper Alderman has appointed a new partner to its litigation team in Sydney with specialist expertise in litigation funding.
Litigation funder Woodsford has struck back at a discrimination suit by a former female director, admitting its CEO described her male colleague as a "thrusting young buck" but denying the phrase was gendered.
Western Sydney University is facing a class action alleging it misled students into studying a health engineering degree that was unaccredited, on the heels of similar claims being leveled at the University of Newcastle.
Commonwealth Bank's New Zealand unit, ASB Bank, has agreed to pay $119.35 million to settle a class action alleging it failed to repay fees and interest wrongly charged to 150,000 customers who took out home or personal loans.
A judge has questioned whether an investor in failed Banksia Securities can bring a case against a court-appointed receiver over his support for a class action settlement later found to involve deception by a team of lawyers.
Another company is being pulled into a class action over a fatal bus crash in NSW's Hunter Valley, with infrastructure consulting firm AECOM planning a cross-claim against engineering firm GHD Australia.
The receiver for Banksia Securities — the failed lender at the centre of a scandal-ridden class action — has argued a new case accusing him of serious misconduct is vexatious and wants a court to release him from the claims.
A judge has allowed a class action over Isuzus that allegedly contained emissions cheat devices to send an opt out notice to group members that includes a warning that if they sell their cars, they may “lose some or all of the money” they could receive in any settlement.
Pharmaceutical giant Johnson & Johnson has denied knowingly selling alleged ineffective medications under its Benadryl, Sudafed and Codral brands, saying research indicated the phenylephrine-containing products worked.